Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

301 results about "Quillaja Saponins" patented technology

Quillaja saponaria saponin (Quillaja saponins) is a heterogenous mixture of molecules varying both in their aglycone and sugar moieties.2 The main aglycone (sapogenin) moiety is quillaic acid, a triterpene of predominantly 30-carbon atoms (hydrophobic) of the ∆12-oleanane type.

Mixture of momordica saponins and polysaccharides and extraction process and application thereof

The invention discloses a mixture of momordica saponins and polysaccharides, which is obtained by the following preparation methods: the balsam pear is used as a raw material and is added with an organic solvent to undergo ultrasound-microwave assisted extraction; a momordica saponins extract is obtained after filtration; momordica filter residues are extracted in alkaline solution; the obtained extract is namely the momordica polysaccharides extract; the momordica saponins extract and the momordica polysaccharides extract are respectively concentrated, dried and mixed to obtain a mixture of momordica polysaccharides and saponins; the invention also discloses an extraction process and application of the mixture of the momordica saponins and polysaccharides; the mixture has various physiological functions such as blood sugar level reduction, cancer resistance, virus resistance, blood lipids regulation, immunity increasing and the like; the mixture can be used for preparing health food with the function of reducing blood sugar level; the extraction process adopts step-by-step extraction technology and has the characteristics of high raw materials utilization rate, mild extraction conditions, high speed, high efficiency and the like; compared with the single extraction technology, for the extraction process of the invention, the extraction time is shortened by more than 20% and the purity of the product is improved by more than 15%.
Owner:SERICULTURE & AGRI FOOD RES INST GUANGDONG ACAD OF AGRI SCI +1

Bone mineral density increase health capsule and preparation method thereof

The invention relates to a bone mineral density increase health capsule and a preparation method thereof. The capsule is composed of a capsule body and a content closed in the capsule body. The content is characterized in that the content comprises 15-30wt% of calcium carbonate, 8-20wt% of chondroitin sulfate, 10-25wt% of D-glucosamine hydrochloride, 0.02-0.2wt% of vitamin K1, 10-20wt% of a collagen polypeptide, 5-15wt% of momordica saponin, 5-15wt% of soybean isoflavone, 5-20wt% of sheep bone marrow peptide powder, 0.1-0.5wt% of vitamin D3 and 0.5-1wt% of an auxiliary material magnesium stearate; and the preparation method comprises the following steps: uniformly stirring the content, sending the uniformly stirred content to a capsule filling machine for filling the content to capsule shells, polishing, choosing, and packaging to obtain the bone mineral density increase health capsule. The health capsule has the advantages of synergistic effect of the above components, common improvement of the absorption of calcium by human bodies, bone mineral density increase, safety, reliability, obvious effect, and carrying and administrating convenience. The preparation method of the health capsule has the advantages of reasonable technology and strong operability.
Owner:WEIHAI BAIHE BIOTECH

Bacillus subtilis SWB8 for producing diosgenin

InactiveCN102061280AAvoid pollutionThe ability to produce diosgenin is stableAntibacterial agentsOrganic active ingredientsBiotechnologyHost plants
The invention discloses a Bacillus subtilis WB8 capable of producing diosgenin, and belongs to the technical field of applied microbiology. The strain is separated from internal issues of subterraneous stems of a medicinal plant of Dioscorea zingiberensis wright, can synthesize and secrete a metabolin of a host plant, namely diosgenin, and has the preservation number of CCTCC (China Center For Type Culture Collection) NO:M2010271; and the strain is rod-like, has the size of 1-1.5*3-5 mu m, forms a single-chain sporocarp, releases endospore, has rough colony with grid bulges, forms pellicle through liquid fermentation, has rich foam, and can grow 16SrDNA core sequence 1542bp with the thermophilic temperature of between 30 and 35 DEG C, the pH of 6.0-9.0 and capacity of tolerating 9.0 percent NaCl, wherein the core sequence has the sequence number of HM210636. The strain liquid is fermented by a common culture medium for 48 to 60 hours, the chloroform extract of the fermentation liquor is the diosgenin, and the diosgenin has the activity of inhibiting pathogenic bacteria and resisting tumor cells. The strain provided by the invention can produce the diosgenin; and compared with the conventional process of extracting the diosgenin from yam plants, the method avoids the pollution of strong acid and yam byproducts on environment, and has potential industrial application prospect.
Owner:SOUTHWEST UNIVERSITY

Method for producing functional foods by simultaneously converting Chinese yam from cordyceps taishanensis

The invention discloses a method for producing functional foods by simultaneously converting Chinese yam from cordyceps taishanensis, and relates to the technical field of bioengineering technology. The preparation method comprises the steps of test tube enlarged cultivation, liquid shake-flask culture and seeding tank enlarged cultivation, solid fermentation culture, drying and smashing in sequence to obtain the functional foods with the effects of regulating blood lipids, blood sugar and blood pressure, resisting radiation and inhibiting tumors. Chinese yam, rice, wheat, corn, sorghum and the like are adopted as a solid substrate, cordyceps taishanensis is adopted as culture, Chinese yam saponin is converted through solid fermentation, and cordycepin and cordyceps polysaccharide are synthesized at the same time; according to the obtained product, the content of saponin of the dry substrate is 2-20 mg/g, the content of sugar of the dry substrate is 10-100 mg/g, and the content of cordycepin of the dry substrate is 1-20 mg/g. The foods can be used for extracting saponin, cordyceps polysaccharide and cordycepin, and producing tablets or capsules for treating and lowering high blood fat, high blood sugar and high blood pressure, resisting radiation and inhibiting tumors.
Owner:JIANGSU UNIV

Facial mask liquid for improving cutis laxa of faces and preparation method thereof

The invention discloses facial mask liquid for improving cutis laxa of faces and a preparation method thereof. The preparation method comprises the following steps: (1) taking 1100-1250 parts by weight of lepidium meyenii extracts, 500-700 parts by weight of broken-wall pine pollen, 280-330 parts by weight of sheep placenta, 25-33 parts by weight of anthocyan, 28-35 parts by weight of coenzyme Q10, 12-16 parts by weight of vitamin C, 19-22 parts by weight of zinc gluconate, 48-53 parts by weight of tocotrienols and 13-16 parts by weight of lecithin to be uniformly mixed so as to obtain a lepidium meyenii composition; (2) taking the lepidium meyenii composition, adding pure water to the taken lepidium meyenii composition, stirring the lepidium meyenii composition and the pure water for 10-15 minutes, heating the lepidium meyenii composition and the pure water which are stirred to 50-60 DEG C, and putting the lepidium meyenii composition and the pure water which are heated into a fluid gyromagnetic magnetizing device for magnetization; and (3) adding tea saponin to the magnetized serosity, and uniformly stirring the tea saponin and the magnetized serosity to obtain the facial mask liquid. According to the invention, the fluid gyromagnetic magnetizing device is used for magnetizing the serosity of the composition, so that the bioactivity and the osmotic force of the composition are obviously enhanced, and when the composition is used for facial care, the composition is easier to absorb.
Owner:FUZHOU PINXING TECH DEV

Method for producing germ oil, oligosaccharides and protein concentrate by using soybean germs

The invention discloses a method for producing products such as soybean germ oil, soybean germ protein concentrate, soybean oligosaccharides, soybean saponins and soybean isoflavones by using soybean germs, and relates to the field of deep grain processing. The method comprises the following steps of: performing online stabilization treatment on the soybean germs; performing normal temperature extraction and low temperature desolventizing by taking subcritical fluid as a lytic enzyme to produce the soybean germ oil; extracting polar ingredients such as the soybean oligosaccharides and the like from the defatted soybean germs by taking subcritical liquid ammonia and the like as lytic enzymes, and separating the oligosaccharides, the isoflavones and the saponins from the extract and purifying; and separating the soybean germ protein concentrate from the liquid ammonia extract, namely a low temperature soybean gear meal. When the method is used, five products such as the germ oil, the oligosaccharides, the soybean protein concentrate and the like can be obtained simultaneously, so that the full utilization of the soybean germs is realized, and production cost is low; reextraction canbe completed in different extraction stages of the same leaching equipment, so that investment is saved; and zero emission is realized, so that the method is environmentally-friendly.
Owner:高邮市日星药用辅料有限公司

Method for utilizing monascus to convert yam to produce functional food

The invention discloses a method for utilizing monascus to convert yam to produce a functional food and relates to the technical field of bioengineering. According to the preparation method, sequentially through the steps of enlarged culture in a test tube, liquid shake-flask culture and enlarged culture in a seed tank, solid fermental cultivation, drying and smashing, the functional food which regulates blood lipids, blood sugar and blood pressure, resists radiation and inhibits tumor is obtained. According to the method, the yam, rice, wheat, corn and sorghum and the like are taken as solid substrates, monascus is taken as a strain to convert yam saponins through solid fermentation, monascus pigment and monascus polysaccharides are synthesized; in the obtained product, the content of the saponins is 2-20 mg/g of dry substrate, the content of the monascus polysaccharides is 10-100 mg/g of dry substrate, the content of lovastatin is 0.5-10 mg/g of dry substrate, the content of the monascus pigment is 1-20 mg/g of dry substrate, and the method can be used for extracting the saponins, the monascus polysaccharides, lovastatin and the monascus pigment and producing tablets or capsules for treating blood lipids, blood sugar and blood pressure, resisting radiation and inhibiting tumor.
Owner:JIANGSU UNIV

NMN (Beta-Nicotinamide Mononucleotide) beneficial bacterium health composition and preparation method and application thereof

The invention relates to the technical field of biological medicine, and discloses an NMN (Beta-Nicotinamide Mononucleotide) beneficial bacterium health composition and a preparation method and application thereof. The composition comprises in parts by weight: 20 to 40 parts of NMN, 10 to 15 parts of beneficial bacterium powder, 0 to 8 parts of betaine, 0 to 5 parts of grape seed extract, 0 to 5 parts of baicalein, 0 to 5 parts of apigenin, 0 to 8 parts of astaxanthin, 0 to 8 parts of ginsenoside, and 0 to 8 parts of ganoderma lucidum polysaccharide (GLP); beneficial bacteria in the NMN beneficial bacterium health composition prepared by the invention can effectively improve the microecology of intestinal floras of a user, not only can improve the metabolic syndrome caused by the intestinal floras of the user, but also can improve the intestinal absorption efficiency, and is beneficial to the absorption of the NMN in the intestinal tract; the ginsenoside and the GLP are mainly matchedto improve the immunity of the user, so that the user can better adapt to various changes of the metabolic pathway level, which are caused by the case that the NAD + level is improved after the NMN enters the human body, and the organism has higher buffering capacity on the changes; and AMPK activators (the betaine, the baicalein and the apigenin) have a synergistic effect with the NMN, so that the NMN beneficial bacterium health composition is better in effect and has no side effects.
Owner:成都及禾生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products